Asperger Syndrome Companies

ID: MRFR/Pharma/4383-HCR

100 Pages

Rahul Gotadki

October 2025

Asperger's Syndrome is no longer officially recognized as a separate diagnosis from Autism Spectrum Disorder (ASD) according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). However, individuals who were previously diagnosed with Asperger's Syndrome are often still identified as having traits associated with high-functioning autism within the broader spectrum.

Asperger Syndrome Market Research Report - Forecast to 2032 Infographic

Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Asperger Syndrome Market

Asperger

Latest Asperger Syndrome Companies Updates:

Akili Interactive Labs receives FDA approval for EndeavorRx This video game-based therapy received approval for improving attention function in children with ASD aged 8-12 years old. This marks a significant advancement in using digital therapeutics for ASD intervention.

Studies on AI-powered tools Companies are actively researching AI-powered tools to analyze language, facial expressions, and eye movements for early detection of ASD in children. Early detection and intervention is crucial for improving long-term outcomes.

List of Asperger Syndrome Key companies in the market:

Eli Lilly and company

Shire

Jazz Pharmaceuticals

Pfizer

GlaxoSmithKline

Forest laboratories

Johnson & Johnson

Bristol-Myers Squibb

Otsuka pharmaceutical

AstraZeneca